New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 18, 2013
10:55 EDTKITD, KITD, CDTI, CDTI, ICUI, ICUI, STMP, STMP, XPL, XPL, XRS, XRS, YOD, YOD, COA, COA, HZNP, HZNP, ICPW, ICPW, BDSI, BDSIRoth Capital to host a conference
25th Annual Roth Conference is being held in Dana Point, California on March 17-20 with webcasted company presentations to begin on March 18 at 11 am; not all company presentations may be webcasted. Webcast Link
News For KITD;ICPW;HZNP;COA;YOD;XRS;XPL;STMP;ICUI;CDTI;BDSI From The Last 14 Days
Check below for free stories on KITD;ICPW;HZNP;COA;YOD;XRS;XPL;STMP;ICUI;CDTI;BDSI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 23, 2014
08:07 EDTICUIICU Medicall's Tego needlefree connector shows positive results in study
Subscribe for More Information
April 22, 2014
05:50 EDTXRSTAL Education sees Q1 revenue $85.9M-$88.4M, consensus $82.21M
Subscribe for More Information
05:49 EDTXRSTAL Education reports Q4 adjusted EPS 24c, consensus 17c
Subscribe for More Information
April 17, 2014
12:00 EDTYODYOU On Demand falls 15.2%
Subscribe for More Information
09:19 EDTYODYOU On Demand mentioned cautiously by Seeking Alpha contributor
Reference Link
09:00 EDTYODYOU On Demand falls 12.2%
Subscribe for More Information
April 16, 2014
09:30 EDTSTMPStamps.com initiated with a Buy at Sidoti
Subscribe for More Information
07:31 EDTHZNPHorizon announces early termination of HSR waiting period for Vidara acquisition
Subscribe for More Information
April 14, 2014
11:09 EDTHZNPOptions with increasing implied volatility: HZNP VJET YOKU CTRX CBS
April 11, 2014
10:35 EDTHZNPHigh option volume stocks: HZNP NI IPG CYTR SNV NBR
Subscribe for More Information
April 10, 2014
07:35 EDTHZNPHorizon Pharma announces patent allowance from USPTO
Horizon Pharma announced that Skyepharma has received a Notice of Allowance from the United States Patent and Trademark Office, or USPTO, for U.S. Patent Application 13/713,528 entitled "Delayed-Release Tablet with Defined Core Geometry" that covers the Company's U.S. approved product RAYOS. This Notice of Allowance concludes the substantive examination of the patent application and will result in the issuance of a U.S. patent after administrative processes are completed. The U.S. patent scheduled to issue from this application will expire in 2024. After issuance, Horizon plans to list the U.S. patent in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, or Orange Book. This will be the fifth U.S. patent to be listed in the Orange Book for RAYOS.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use